Vinva Investment Management Ltd raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 17.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 60,449 shares of the healthcare product maker’s stock after purchasing an additional 9,017 shares during the period. Vinva Investment […]